Search by Drug Name or NDC
NDC 69097-0408-15 METOPROLOL SUCCINATE 100 mg/1 Details
METOPROLOL SUCCINATE 100 mg/1
METOPROLOL SUCCINATE is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cipla USA Inc.. The primary component is METOPROLOL SUCCINATE.
MedlinePlus Drug Summary
Metoprolol is used alone or in combination with other medications to treat high blood pressure. It also is used to prevent angina (chest pain) and to improve survival after a heart attack. Metoprolol also is used in combination with other medications to treat heart failure. Metoprolol is in a class of medications called beta blockers. It works by relaxing blood vessels and slowing heart rate to improve blood flow and decrease blood pressure. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 69097-0408-15Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Metoprolol
Product Information
| NDC | 69097-0408 |
|---|---|
| Product ID | 69097-408_95bb3551-0e88-47cc-95e9-35c6dc731faf |
| Associated GPIs | 33200030057530 |
| GCN Sequence Number | 016600 |
| GCN Sequence Number Description | metoprolol succinate TAB ER 24H 100 MG ORAL |
| HIC3 | J7C |
| HIC3 Description | BETA-ADRENERGIC BLOCKING AGENTS |
| GCN | 20742 |
| HICL Sequence Number | 006323 |
| HICL Sequence Number Description | METOPROLOL SUCCINATE |
| Brand/Generic | Generic |
| Proprietary Name | METOPROLOL SUCCINATE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | metoprolol succinate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/1 |
| Substance Name | METOPROLOL SUCCINATE |
| Labeler Name | Cipla USA Inc. |
| Pharmaceutical Class | Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA207465 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69097-0408-15 (69097040815)
| NDC Package Code | 69097-408-15 |
|---|---|
| Billing NDC | 69097040815 |
| Package | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (69097-408-15) |
| Marketing Start Date | 2019-03-25 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.10542 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | METOPROLOL SUCC ER 100 MG TAB |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |